THE HEALTH CELL: Rise of AI in Clinical Trials Luncheon

August 25, 2022

—ATTEND IN PERSON— New drug development is a huge endeavor that can take 15 years, cost > $2B and still have a 80 – 90% failure rate. Now new applications of AI may streamline this process by predictive modeling that increases drug safety, decreases development cost and time to market, and improves overall patient outcomes.

More information

View full calendar